{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:13:52Z","timestamp":1776402832728,"version":"3.51.2"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T00:00:00Z","timestamp":1233792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Aluminium (ALUM) is used as experimental and clinical adjuvant for parenteral vaccine formulation. It is also contained in anti\u2010acid drugs like sucralfate (SUC). These anti\u2010acids have been shown to cause sensitization to food proteins via elevation of the gastric pH. The aim of this study was to assess the oral adjuvant properties of ALUM, alone or contained in SUC, in a BALB\/c mouse model.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Mice were fed SUC plus ovalbumin (OVA) and compared with groups where ALUM or proton pump inhibitors (PPI) were applied as adjuvants. The humoral and cellular immune responses were assessed on antigen\u2010specific antibody and cytokine levels. The <jats:italic>in vivo<\/jats:italic> relevance was investigated in skin tests.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The highest OVA\u2010specific immunoglobulin G1 (IgG1) and IgE antibody levels were found in mice fed with OVA\/SUC, followed by OVA\/ALUM\u2010treated animals, indicating a T helper 2 (Th2) shift in both groups. Antibody levels in other groups revealed lower (OVA\/PPI\u2010group) or baseline levels (control groups). Positive skin tests confirmed an allergic response in anti\u2010acid or adjuvant\u2010treated animals.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Our data show for the first time that ALUM acts as a Th2\u2010adjuvant via the oral route. This suggests that orally applied SUC leads to an enhanced risk for food allergy, not only by inhibiting peptic digestion but also by acting as a Th2\u2010adjuvant by its ALUM content.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2008.01933.x","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T04:48:45Z","timestamp":1233982125000},"page":"890-897","source":"Crossref","is-referenced-by-count":29,"title":["Aluminium <i>per se<\/i> and in the anti\u2010acid drug sucralfate promotes sensitization via the oral route"],"prefix":"10.1111","volume":"64","author":[{"given":"R.","family":"Brunner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wallmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Szalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Altmeppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Riemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jensen\u2010Jarolim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pali\u2010Sch\u00f6ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,5,11]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3038.1999.101008.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.014"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.05.048"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02333.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.12.671"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1079\/PNS2002184"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2007.03.006"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/81.1.154"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(03)01719-6"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7223com"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3170fje"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.032"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02813.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/enrs.2002.4352"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2000.1441"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/02652030500073584"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl569"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1096-1269"},{"key":"e_1_2_7_20_2","first-page":"143","article-title":"Modulation of the human immune response by the non\u2010toxic and non\u2010pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation","volume":"61","author":"Mannhalter JW","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.08.006"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)91026-2"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90566-2"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3597(03)90096-2"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1208\/pt070109"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.029"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0818-9641.2004.01286.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.10.023"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.26.969"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2008.01933.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2008.01933.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:14:20Z","timestamp":1697429660000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2008.01933.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1398-9995.2008.01933.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01933.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,11]]}}}